CSN Login
Members Online: 3

You are here

CSN Home › Discussion boards › Cancer specific › Kidney Cancer

Atezolizumab Trial as Adjuvant Therapy Targeting PDL1 After Nephrectomy M0

Supersum's picture
Supersum
Posts: 109
Joined: Aug 2017
Sep 02, 2017 - 8:28 pm

Roche is running a trial:

"A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy (IMmotion010)"

I have started on the trial and had my first infusion last week.

Read more and check locations here:

https://clinicaltrials.gov/ct2/show/NCT03024996

 

 
Supersum's picture
Supersum
Posts: 109
 Joined: Aug 2017
Sep 05, 2017 - 5:04 am

Forgot to mention please ask me if you have any questions or just leave any general comments or advice, that would be great.

Would also be great to hear from the other 663 participants in the trial to share notes  Smile
Subscribe to Comments for "Atezolizumab Trial as Adjuvant Therapy Targeting PDL1 After Nephrectomy M0 "

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2019 © Cancer Survivors Network